title: GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.
abstract: MPTP-induced dopaminergic neurotoxicity involves major biochemical processes such as oxidative stress and impaired energy metabolism, leading to a significant reduction in the number of nigrostriatal dopaminergic neurons. Glutathione S-transferase pi (GSTpi) is a phase II detoxifying enzyme that provides protection of cells from injury by toxic chemicals and products of oxidative stress. In humans, polymorphisms of GSTP1 affect substrate selectivity and stability increasing the susceptibility to parkinsonism-inducing effects of environmental toxins. Given the ability of MPTP to increase the levels of reactive oxygen species and the link between altered redox potential and the expression and activity of GSTpi, we investigated the effect of MPTP on GSTpi cellular concentration in an in vivo model of Parkinson's disease. The present study demonstrates that GSTpi is actively expressed in both substantia nigra pars compacta and striatum of C57BL/6 mice brain, mostly in oligodendrocytes and astrocytes. After systemic administration of MPTP, GSTpi expression is significantly increased in glial cells in the vicinity of dopaminergic neurons cell bodies and fibers. The results suggest that GSTpi expression may be part of the mechanism underlying the ability of glial cells to elicit protection against the mechanisms involved in MPTP-induced neuronal death.
authors.affiliation: Research Institute for Medicines and Pharmaceutical Sciences-iMED.UL, University of Lisbon, Av. Prof. Gama Pinto, 1649-003, Lisbon, Portugal.
authors.forename: Margarida
authors.initials: M
authors.lastname: Castro-Caldas
authors.forename: Andreia
authors.initials: A
authors.lastname: Neves Carvalho
authors.forename: Isabel
authors.initials: I
authors.lastname: Peixeiro
authors.forename: Elsa
authors.initials: E
authors.lastname: Rodrigues
authors.forename: Maria Celeste
authors.initials: MC
authors.lastname: Lechner
authors.forename: Maria João
authors.initials: MJ
authors.lastname: Gama
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000818:Animals; D053148:Caspase 3 / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000473:pathology; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000494:pharmacology; D051549:Glutathione S-Transferase pi / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D020267:MPTP Poisoning / Q000378:metabolism*; D008636:Mesencephalon / Q000187:drug effects / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D009410:Nerve Degeneration / Q000139:chemically induced / Q000473:pathology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D051028:bcl-2-Associated X Protein / Q000378:metabolism
chemical_list: D015259:Dopamine Agents; D007527:Isoenzymes; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D014446:Tyrosine 3-Monooxygenase; D051549:Glutathione S-Transferase pi; D053148:Caspase 3; D004298:Dopamine
references.citation: Brain Res. 1997 Feb 21;749(1):44-52
references.pmid: 9070626
references.citation: Annu Rev Pharmacol Toxicol. 2005;45:51-88
references.pmid: 15822171
references.citation: Trends Mol Med. 2003 Aug;9(8):360-5
references.pmid: 12928038
references.citation: Brain Res. 1997 Nov 28;777(1-2):110-8
references.pmid: 9449419
references.citation: Glia. 2005 Nov 1;52(2):144-52
references.pmid: 15920722
references.citation: Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8
references.pmid: 12666096
references.citation: Acta Neuropathol. 2003 Dec;106(6):518-26
references.pmid: 14513261
references.citation: Adv Neurol. 1987;45:19-34
references.pmid: 2881444
references.citation: Lancet. 1998 Oct 24;352(9137):1344-6
references.pmid: 9802272
references.citation: Proc Natl Acad Sci U S A. 2005 May 31;102(22):8024-9
references.pmid: 15911761
references.citation: J Neurosci Res. 2002 Jul 1;69(1):24-9
references.pmid: 12111812
references.citation: Neurobiol Aging. 2003 May-Jun;24(3):501-9
references.pmid: 12600725
references.citation: Mov Disord. 2003 Feb;18(2):121-9
references.pmid: 12539204
references.citation: Brain Res. 2007 Mar 23;1138:196-202
references.pmid: 17275793
references.citation: Neurotoxicol Teratol. 2002 Sep-Oct;24(5):599-605
references.pmid: 12200191
references.citation: Glia. 1998 Apr;22(4):408-14
references.pmid: 9517573
references.citation: J Neurochem. 2001 Jun;77(5):1362-71
references.pmid: 11389187
references.citation: J Neural Transm (Vienna). 2006 Jun;113(6):757-67
references.pmid: 16755380
references.citation: Nat Neurosci. 2008 Jul;11(7):755-61
references.pmid: 18536709
references.citation: Neurotoxicology. 1995 Fall;16(3):425-40
references.pmid: 8584275
references.citation: CRC Crit Rev Biochem. 1988;23(3):283-337
references.pmid: 3069329
references.citation: Methods Enzymol. 2005;401:1-8
references.pmid: 16399376
references.citation: Adv Neurol. 1999;80:3-7
references.pmid: 10410696
references.citation: Drug Resist Updat. 1999 Jun;2(3):143-147
references.pmid: 11504484
references.citation: Mov Disord. 2008 Mar 15;23(4):474-83
references.pmid: 18044695
references.citation: Eur J Neurosci. 2003 Jan;17(1):1-12
references.pmid: 12534964
references.citation: EMBO J. 1999 Mar 1;18(5):1321-34
references.pmid: 10064598
references.citation: Neurobiol Dis. 2000 Aug;7(4):240-50
references.pmid: 10964596
references.citation: Cell. 1993 Oct 22;75(2):241-51
references.pmid: 7503812
references.citation: Brain Res. 1991 Nov 8;564(1):31-6
references.pmid: 1777821
references.citation: Eur J Neurol. 2007 Feb;14(2):156-61
references.pmid: 17250723
references.citation: Adv Neurol. 1999;80:271-86
references.pmid: 10410732
references.citation: J Neural Transm Suppl. 1999;56:113-25
references.pmid: 10370906
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1977-82
references.pmid: 17267597
references.citation: Pharmacology. 2000 Sep;61(3):154-66
references.pmid: 10971201
references.citation: J Biol Chem. 2007 Feb 16;282(7):4364-4372
references.pmid: 17158454
references.citation: Brain Res Brain Res Protoc. 2002 Apr;9(2):105-11
references.pmid: 12034329
references.citation: J Neurosci Res. 2000 Jan 1;59(1):126-35
references.pmid: 10658193
references.citation: Pol J Pharmacol. 2003 Sep-Oct;55(5):881-5
references.pmid: 14704482
references.citation: Cancer Res. 2000 Aug 1;60(15):4053-7
references.pmid: 10945608
references.citation: Mol Cell Biol. 2006 Jan;26(1):221-9
references.pmid: 16354693
references.citation: Nature. 1995 Jan 26;373(6512):335-9
references.pmid: 7830766
references.citation: Neurosci Lett. 2004 Jun 17;363(3):243-6
references.pmid: 15182952
references.citation: Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S3-7
references.pmid: 15109580
references.citation: Neuroscience. 2007 Aug 24;148(2):535-40
references.pmid: 17681700
references.citation: Brain Res Mol Brain Res. 2005 Mar 24;134(1):170-9
references.pmid: 15790541
references.citation: J Neurosci. 2003 Apr 15;23(8):3394-406
references.pmid: 12716947
references.citation: J Biochem Mol Biol. 2004 Mar 31;37(2):139-43
references.pmid: 15469687
references.citation: Neurodegeneration. 1995 Sep;4(3):257-69
references.pmid: 8581558
references.citation: Adv Neurol. 1999;80:9-18
references.pmid: 10410697
references.citation: J Neural Transm (Vienna). 2001;108(11):1263-82
references.pmid: 11768626
references.citation: Neurodegeneration. 1996 Jun;5(2):137-43
references.pmid: 8819134
references.citation: Ann N Y Acad Sci. 2003 Jun;991:120-31
references.pmid: 12846981
references.citation: Glia. 1998 Apr;22(4):371-8
references.pmid: 9517569
references.citation: J Bioenerg Biomembr. 2004 Aug;36(4):375-9
references.pmid: 15377875
references.citation: J Biol Chem. 2003 Jun 20;278(25):22243-9
references.pmid: 12646564
references.citation: Biol Chem. 2003 Apr;384(4):505-16
references.pmid: 12751781
references.citation: Int J Biochem. 1994 Mar;26(3):295-308
references.pmid: 8187927
references.citation: J Biol Chem. 2003 Feb 14;278(7):4536-41
references.pmid: 12446695
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):254-8
references.pmid: 17034008
references.citation: Neuron. 2003 Sep 11;39(6):889-909
references.pmid: 12971891
references.citation: Biochem J. 1997 May 15;324 ( Pt 1):25-8
references.pmid: 9164836
references.citation: J Neural Transm (Vienna). 2004 Dec;111(12):1543-73
references.pmid: 15455214
references.citation: Curr Pharm Des. 2006;12(27):3521-33
references.pmid: 17017945
references.citation: J Neurochem. 2000 Sep;75(3):1200-8
references.pmid: 10936203
references.citation: Crit Rev Biochem Mol Biol. 1995;30(6):445-600
references.pmid: 8770536
references.citation: Biochim Biophys Acta. 1997 Nov 28;1362(1):77-86
references.pmid: 9434102
references.citation: J Neurosci. 1996 Jan 15;16(2):486-96
references.pmid: 8551333
references.citation: J Neurosci Res. 1995 Feb 1;40(2):269-75
references.pmid: 7745620
references.citation: Neuroscience. 1997 Apr;77(4):1037-48
references.pmid: 9130785
references.citation: J Neurochem. 1991 Jul;57(1):95-102
references.pmid: 1711102